Rhinocerebral mucormycosis (RCM): To study the clinical spectrum and outcome of 61 cases of RCM managed at a tertiary care center in India
Authors:
- Anil Kumar SharmaASAnil Kumar Sharma
- Charandeep Singh GandhokeCGCharandeep Singh Gandhoke
- Siddharth SharmaSSSiddharth Sharma
- Mohit JunejaMJMohit Juneja
- Zijano M. KithanZKZijano M. Kithan
- Aakash AggarwalAAAakash Aggarwal
- Rupa MehtaRMRupa Mehta
- Simran SyalSSSimran Syal
- Shailendra D. AnjankarSAShailendra D. Anjankar
Open Access
- 20 January 2023
- journal article
- research article
- Published by Scientific Scholar in Surgical Neurology International
- Vol. 14, 15
Abstract
Background: Mucormycosis is a life-threatening infection of the paranasal sinuses and nasal cavities that can easily spread to the orbit and the brain. It is caused by fungi of the family Mucoraceae. We present a case series of 61 patients diagnosed and treated for rhinocerebral mucormycosis (RCM) at a single tertiary health care center. Methods: After obtaining ethical clearance, all patient files with a final diagnosis of RCM were thoroughly analyzed in departmental records and a master chart was prepared. The study evaluated the etiology, clinical spectrum, diagnosis, management, complications, and outcome at 3 months of RCM cases. Results: About 93.4% of the RCM cases were diabetic and an equal number had a past history of COVID infection. About 85.2% had received steroids for the treatment of coronavirus disease 2019 infection. The most common presentation of RCM was temporal lobe abscess (25.7%) followed by frontal lobe abscess (16.6%). At 3 months post-diagnosis, mortality in our study was 42.6%. About 26.2 % of the RCM cases had no disease, 23% had a static disease, and 8.2% had progressive disease at the end of 3 months. Conclusion: We report the largest single-center case series of RCM, comprising 61 patients. This case series underscores the importance of the early diagnosis and prompt treatment for a better prognosis for this dreadful disease. The three pillars of treatment for RCM cases include reversal of the immunosuppressive state, administration of antifungal drugs, and extensive surgical debridement. In spite of all this, mortality remains high.Keywords
This publication has 8 references indexed in Scilit:
- Multidisciplinary Management of COVID-Associated Mucormycosis Syndemic in IndiaIndian Journal of Surgery, 2021
- Multicenter Epidemiologic Study of Coronavirus Disease–Associated Mucormycosis, IndiaEmerging Infectious Diseases, 2021
- A case series of post COVID-19 mucormycosis—a neurological prospectiveThe Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 2021
- Rhinocerebral Mucormycosis: A Ten-Year Single Centre Case SeriesCureus, 2020
- Nasal Mucormycosis: Our experience with 24 casesOtolaryngologia Polska, 2020
- Mucormycosis2019
- Rhinocerebral mucormycosis: the disease spectrum in 27 patientsMycoses, 2007
- Rhinocerebral mucormycosis: pathways of spreadEuropean Archives of Oto-Rhino-Laryngology, 2005